home / stock / sgmo / sgmo quote
Last: | $0.4596 |
---|---|
Change Percent: | -3.72% |
Open: | $0.446 |
Close: | $0.4596 |
High: | $0.4794 |
Low: | $0.42 |
Volume: | 1,989,152 |
Last Trade Date Time: | 07/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.4596 | $0.446 | $0.4596 | $0.4794 | $0.42 | 1,989,152 | 07-16-2024 |
$0.43 | $0.46 | $0.43 | $0.4798 | $0.4007 | 2,173,307 | 07-15-2024 |
$0.4548 | $0.45 | $0.4548 | $0.48 | $0.4298 | 3,784,661 | 07-12-2024 |
$0.4384 | $0.4345 | $0.4384 | $0.4515 | $0.405 | 2,879,223 | 07-11-2024 |
$0.3988 | $0.3456 | $0.3988 | $0.4 | $0.3407 | 2,866,248 | 07-10-2024 |
$0.35 | $0.33 | $0.35 | $0.3579 | $0.32 | 1,520,343 | 07-09-2024 |
$0.3184 | $0.32 | $0.3184 | $0.3273 | $0.3055 | 1,565,621 | 07-08-2024 |
$0.3225 | $0.33 | $0.3225 | $0.3432 | $0.304 | 3,245,570 | 07-05-2024 |
$0.322 | $0.3301 | $0.322 | $0.3538 | $0.3205 | 1,643,578 | 07-04-2024 |
$0.322 | $0.3301 | $0.322 | $0.3538 | $0.3205 | 1,643,578 | 07-03-2024 |
$0.3201 | $0.3315 | $0.3201 | $0.35 | $0.3131 | 2,562,552 | 07-02-2024 |
$0.33 | $0.3972 | $0.33 | $0.4 | $0.33 | 2,926,201 | 07-01-2024 |
$0.3583 | $0.4071 | $0.3583 | $0.419999 | $0.3526 | 20,221,130 | 06-28-2024 |
$0.3986 | $0.4263 | $0.3986 | $0.4473 | $0.39 | 3,094,698 | 06-27-2024 |
$0.4234 | $0.45 | $0.4234 | $0.469 | $0.4215 | 1,629,744 | 06-26-2024 |
$0.4466 | $0.4641 | $0.4466 | $0.4785 | $0.442 | 1,785,843 | 06-25-2024 |
$0.4698 | $0.4447 | $0.4698 | $0.482 | $0.4401 | 1,996,000 | 06-24-2024 |
$0.4448 | $0.4525 | $0.4448 | $0.4638 | $0.4358 | 2,257,481 | 06-21-2024 |
$0.4505 | $0.4251 | $0.4505 | $0.4644 | $0.4223 | 1,995,700 | 06-20-2024 |
$0.4212 | $0.42 | $0.4212 | $0.4683 | $0.4 | 2,053,389 | 06-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Sangamo Therapeutics Inc. Company Name:
SGMO Stock Symbol:
NASDAQ Market:
Sangamo Therapeutics Inc. Website:
2024-05-15 13:30:05 ET H.C. Wainwright analyst issues UNDERPERFORM recommendation for SGMO on May 15, 2024 11:01AM ET. The previous analyst recommendation was Underperform. SGMO was trading at $0.5901 at issue of the analyst recommendation. The overall analyst consensus ...
Showcased 20 presentations at the 27 th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting demonstrating progression of neurology-focused preclinical pipeline, including additional data from novel delivery capsid, STAC-BBB, that demonstrated industry-leading blood-brain barrie...
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on Sangamo’s deep expertise in protein-DNA interactions derived from...